EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

An in vitro batch culture study to assess the fermentation of human milk oligosaccharides by faecal microbiota from healthy and irritable bowel syndrome stool donors

Patricia Sanz Morales iD, Anisha Wijeyesekera, M Denise Robertson, Giles Major, Claire L Boulangé, Peter Philip James Jackson iD, Carlos Guillermo Poveda Turrado, Glenn R Gibson

Gut Microbiome · 2025 · 6

DOI: 10.1017/gmb.2025.2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Gut Microbiome, online erschienen am 20.03.2025. Verfasst von Patricia Sanz Morales und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Food and Nutritional Sciences, The University of Reading, Reading, UK. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study explored the effects of different human milk oligosaccharides (HMOs), solely and in combination, on gut microbiota composition and metabolic activity (organic acid production), using anaerobic in vitro batch culture fermenters. The aim was to compare prebiotic effects of HMOs (2’FL, 3’FL, 3’SL, 6’SL, LNT, LNnT, and 1:1 ratio mixes of 2’FL/3’SL and 3’SL/LNT) in faecal samples from irritable bowel syndrome (IBS) donors and healthy controls, and to determine the best-performing HMO in IBS. Fluorescent in situ hybridisation coupled with flow cytometry was utilised to study microbiota changes in major colonic genera, and organic acid production was assessed by gas chromatography. IBS donors had different starting microbial profiles compared to healthy controls and lower levels of organic acids. In response to HMOs, there were alterations in both the control and IBS faecal microbiomes. In IBS donor fermenters, Bifidobacterium , Faecalibacterium , total bacterial numbers, and organic acid production significantly increased post-HMO intervention. When comparing the effect of HMO interventions on the microbiota and organic acid production, a mix of 3’SL/LNT HMOs may be the most promising intervention for IBS patients.

Schlagwörter

Stichwörter der Autor:innen

IBSgut microbiomehuman milk oligosaccharides

Autor:innen und Institutionen

  • Department of Food and Nutritional Sciences, The University of Reading, Reading, UK.
  • Department of Nutrition, Food and Exercise Sciences, Health & Medical Sciences, University of Surrey, Guildford, UK.
  • Nestlé Institute of Health Sciences, Nestlé Research, Lausanne, Switzerland.
  • Department of Food Science, Purdue University, West Lafayette, IN, USA.

ORCID-Profile: Patricia Sanz Morales, Peter Philip James Jackson

Zitieren

APA

Sanz Morales, P., Wijeyesekera, A., Robertson, M. D., Major, G., Boulangé, C. L., Jackson, P. P. J., Poveda Turrado, C. G., & Gibson, G. R. (2025). An in vitro batch culture study to assess the fermentation of human milk oligosaccharides by faecal microbiota from healthy and irritable bowel syndrome stool donors. Gut Microbiome, 6. https://doi.org/10.1017/gmb.2025.2

Vancouver

Sanz Morales P, Wijeyesekera A, Robertson MD, Major G, Boulangé CL, Jackson PPJ, et al. An in vitro batch culture study to assess the fermentation of human milk oligosaccharides by faecal microbiota from healthy and irritable bowel syndrome stool donors. Gut Microbiome. 2025;6. doi:10.1017/gmb.2025.2

BibTeX
@article{SanzMorales2025,
  author = {Sanz Morales, Patricia and Wijeyesekera, Anisha and Robertson, M Denise and Major, Giles and Boulangé, Claire L and Jackson, Peter Philip James and Poveda Turrado, Carlos Guillermo and Gibson, Glenn R},
  title = {An in vitro batch culture study to assess the fermentation of human milk oligosaccharides by faecal microbiota from healthy and irritable bowel syndrome stool donors},
  journal = {Gut Microbiome},
  year = {2025},
  volume = {6},
  doi = {10.1017/gmb.2025.2}
}
Kostenlos starten →